GlassScriptPhysician profile
Michael D Finn
NPI 1891746319
$1,716.59
in general payments reported to CMS, 2019-2025
16 companies · $1,371 in 2025
The $1,371 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.94 · 2021: $50.18 · 2022: $65.74 · 2023: $118 · 2024: $57.73 · 2025: $1,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $840 · Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $840.42 |
| Food and Beverage | $706.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $1,342.04 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $48.38 | 2023 | Arcalyst |
| Abbott Laboratories | $47.92 | 2020-2024 | Diamondback Peripheral |
| Merck Sharp & Dohme LLC | $47.15 | 2021-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $32.77 | 2022 | |
| Boston Scientific Corporation | $27.40 | 2020 | |
| Corcept Therapeutics | $24.67 | 2023 | Korlym |
| Janssen Pharmaceuticals, INC | $20.70 | 2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $20.00 | 2024 | Arcalyst |
| Pfizer INC. | $18.57 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.11 | 2022 | |
| Impulse Dynamics (USA) INC. | $14.86 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $14.33 | 2021 | |
| Nevro Corp. | $13.65 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.31 | 2023 | Seglentis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Finn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.